Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 16,154 shares at $9.26 ($150K) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Open-market sale of $150k KALV by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.26 | 8,077 | $75K | 50.0% |
| 2 | $9.26 | 8,077 | $75K | 50.0% |
| Total | $9.26 avg | 16,154 | $150K | 100% |
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |